Cardiovascular Disease

Delivering global market research insights in the cardiovascular disease area

New treatment options for cardiovascular disease such as new oral anticoagulants, PCSK9 inhibitors for use in cholesterol management and new options for degenerative heart value disease are all exciting developments within this therapy area. New guidelines from the USA on cholesterol and hypertension treatment now focus on outcomes rather than reaching specific numerical targets. This provides an opportunity for pharma companies with drugs treating these diseases to empower physicians to provide more personalised care. But the escalating costs of these new treatments means there is increased pressure from regulators and payers for brands to demonstrate value.

Our experience in cardiovascular covers many disease areas including heart failure, circulatory disorders, hypertension, cholesterol, dyslipidemia, angina, arrhythmias and stroke.

We can help you with:

  • Opportunity and demand assessment

  • Understanding the global and local market opportunity

  • The patient journey and unmet needs

  • Segmenting the market

  • Product and portfolio development

  • Brand positioning, launch and beyond

Cardiovascular resources:

blood pressure monitor-small resource image

Case study

How a two-phase evaluation involving interactive workshops gave guidance for improving a Patient Assistance Programme in CV.

Learn more

doctor with ipad 2

Case study

How a mobile methodology elicited a deeper understanding of the key drivers behind physicians’ prescribing decisions.

Learn more

Hyperlipidemia article- small resource image

Article

Hyperlipidemia: Are the PCSK9 inhibitors bouncing back?


 

Find out more